Trial
NCT00476996
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Genentech, Inc.
Collaborators
Roche Pharma AG
Condition
Rheumatoid Arthritis
Intervention
Leflunomide
Why stopped
Recruitment was fully completed for this study; however, the study was terminated during conduct after the primary endpoint analysis was completed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-12